Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-18

Clinical Trial Update: Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS [NA]

View source ↗

Summary

This trial update reports on the safety and tolerability of serum-derived bovine immunoglobulin in pediatric patients with diarrhea-predominant irritable bowel …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serum-Derived Bovine Immunoglobulin (serum-derived bovine immunoglobulin)

Snippet

Sponsor: Connecticut Children's Medical Center | Conditions: Diarrhea Predominant Irritable Bowel Syndrome | NA | Status: COMPLETED